Clinical Trials Update: Jan. 9, 2008
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
181893
The U.S. Food and Drug  Administration on Thursday ordered the review of preventative  studies involving Pfizer Inc.'s painkillers Celebrex and  Bextra, in light of recent evidence they may increase the risk  of heart attack and stroke.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
425170
Faced with weak development pipelines that are putting a drag on stock prices, drug manufacturers are retooling the decades-old system of clinical trials to make it faster and cheaper.
189691
Elson So, MD, of the Mayo Clinic in Rochester, Minn., and colleagues report their findings in the Nov. 9 issue of the journal Neurology.
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
552158
It can be incredibly difficult for patients to ferret out studies of experimental drugs that offer hope to threat their disease. There is no comprehensive database of ongoing clinical trials, but specialists offer advice for the search:
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
217395
Pfizer Inc's experimental oral biotechnology drug axitinib demonstrated substantial anti-tumor activity in patients with advanced thyroid cancer in a small, mid-stage clinical trial, according to data released at a major cancer meeting on Saturday.
254822
In a clinical trial of about 200 patients, an experimental drug from Eli Lilly lessened schizophrenia symptoms without the serious side effects of current treatments, according to a paper published Sunday in the journal Nature.
370141
FRIDAY, Jan. 11 (HealthDay News) -- Therapeutic vaccines to fight ovarian and breast cancer are in the first stage of clinical trials to determine their safety and effectiveness, researchers report.
61937
NEW YORK - Johnson &amp; Johnson and Boston Scientific Corp. reported new safety data yesterday for drug-coated stents that may help revive sales depressed by prior reports linking the devices to a higher risk of heart attacks.
52664
MONDAY, Oct. 18 (HealthDayNews) --The National Institute on Aging has launched a landmark study aimed at finding a way to use imaging technology to reduce the time and cost of clinical trials for Alzheimer's disease medications.
693379
questions over testing of a key HIV/AIDS drug before a US-backed roll-out of the treatment across the continent. Ingelheim to hide adverse effects of nevirapine when used to try to prevent mother-to-child HIV transmission.
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
478882
Pfizer (PFE) said Friday that is has received new information about the cardiovascular safety of its popular arthritis drug Celebrex, based on an analysis of a long-term cancer trial.
45895
LONDON (CBS.MW) -- Bayer (BAY) (DE:575200) and Onyx Pharmaceuticals (ONXX) said its Phase II study on a kidney cancer drug met its primary endpoint, with 70 percent showing tumor shrinkage or disease stabilization.